Protein Sciences, Liomont deal

By WIR Staff | Sep 8, 2014 | 7:00 AM GMT

Protein Sciences granted Liomont exclusive rights to manufacture and commercialize Protein Sciences' Flublok seasonal influenza vaccine and Panblok pandemic